|
Index of reports
> Cases resulting in other serious reactions (94)
> Cases with Hyperthyroidism (7)
Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in other serious reactions where reactions include hyperthyroidism.
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-26
Patient: 83 year old male
Adverse reactions / side effects: Congestive Cardiomyopathy, Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Indication: Brain Neoplasm
Kardegic
Administration route: Oral
Indication: Myocardial Infarction
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
Indication: Myocardial Infarction
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
Indication: Myocardial Infarction
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-25
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-24
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-24
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-20
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Omeprazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
Adverse event in 83 year old male receiving Micardis (Telmisartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-15
Patient: 83 year old male
Adverse reactions / side effects: Hyperthyroidism
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Temgesic
Administration route: Oral
Kardegic
Administration route: Oral
End date: 2006-06-08
Mopral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Micardis
Administration route: Oral
Indication: Essential Hypertension
End date: 2006-06-08
Nitroderm
Administration route: Topical
End date: 2006-06-18
Hemigoxine Nativelle
Administration route: Oral
End date: 2006-06-08
|
